The Centers for Disease Control and Prevention (CDC) has taken a significant step to address issues in healthcare related to gender detransitioning. This move aims to provide justice and improved medical care for patients who have undergone gender-affirming treatments but wish to return to their biological gender.
Previously, healthcare documentation did not include specific codes for those who decide to reverse gender transition. Diagnosis codes are crucial, as they help track patient ailments in medical records and facilitate treatment and billing. As of now, many transitioning patients have had comprehensive healthcare documentation. Yet, those attempting to detransition have remained largely unseen by the system.
Since 2015, the CDC has adopted numerous codes from the World Health Organization for gender-related treatments. However, codes for reverting to a previous gender have been absent, leaving detransitioners without formal recognition. This situation has led to difficulties in receiving appropriate care, as demonstrated by a case involving a young woman who faced menopause earlier due to a lack of correct treatment records.
The absence of specific codes has prevented healthcare providers from accurately treating and documenting patients who chose to return to their biological gender. For instance, a patient receiving an inappropriate dose of estrogen underscores the need for these new codes. Over 14,000 children have undergone sex-change treatments, with many potentially seeking to revert their changes in the future. Such patients require access to the right healthcare support, including hormone replacement or mental health services.
With the introduction of new diagnosis codes, the CDC acknowledges the needs of detransitioners. Scheduled for formal issuance in October, these codes were developed with guidance from recommendations made earlier this year. They will empower healthcare providers to plan suitable care for detransitioning individuals and give researchers data to enhance patient care in the future.
The establishment of these codes will help American healthcare accurately count detransitioners. Advocates have often opposed recognizing these patients, misunderstanding them as a threat to transgender health advocacy. Nonetheless, prioritizing healthcare transparency and reducing stigma for anyone seeking treatment is essential.
The CDC’s initiative serves as a model for global healthcare standards. By addressing detransitioning within the medical system, detransitioners can finally receive the compassionate and comprehensive care they deserve.
Dr. Aida Cerundolo, an emergency medicine physician and senior fellow at Do No Harm.
© 2026 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.